Autoimmune Bullous Dermatosis Clinical Trials
2 recruiting trials for Autoimmune Bullous Dermatosis. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Autoimmune Bullous Dermatosis clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Assistance Publique - Hôpitaux de Paris (1), University Hospital, Toulouse (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Sampling (other, 2 trials), followed by Blood sampling, Remainders of samples taken as part of the treatment.
Track Autoimmune Bullous Dermatosis trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic...
Chronic inflammatory skin diseases constitute a heterogeneous group of pathologies. They affect the skin but also other organs (joints, lungs, muscles, etc.). Their prognosis and...
Clinico-biological Collection of Autoimmune, Dysimmune or Auto-inflammatory Dermatological Diseases
The aim of this project is to start a biological and clinical collection of patients presenting autoimmune, dysimmune or auto-inflammatory dermatological diseases. This collection...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Autoimmune Bullous Dermatosis, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Autoimmune Bullous Dermatosis, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Autoimmune Bullous Dermatosis, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.